SEAN JACKSON: Open Payments
NPI 1720685050 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 36 payments from 13 companies in 2025. Trend: 2023 $3,328 · 2024 $3,719 · 2025 $782
Food & beverage: $698Education: $84
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $144 |
| ABBVIE INC. | 5 | $118 |
| Janssen Biotech, Inc. | 2 | $107 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| UCB, Inc. | 4 | $81 |
| Amgen Inc. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Lilly USA, LLC | 2 | $37 |
| Madrigal Pharmaceuticals | 1 | $34 |
| ORPHALAN INC | 1 | $25 |
Products named: XELJANZ, TREMFYA, COSENTYX, Bimzelx, SKYRIZI, RINVOQ, OTEZLA, BENLYSTA.
Industry payments across AL — which companies pay providers there.
